Labetalol Use in Severe Aortic Stenosis

Introduction to Labetalol Use

The American College of Cardiology recommends labetalol can be used safely in patients with severe aortic stenosis when there are compelling indications such as heart failure with reduced ejection fraction, post-myocardial infarction status, arrhythmias requiring rate control, or angina pectoris, but should be avoided as first-line therapy for hypertension alone 1, 2, 3

Beta-blockers, including labetalol, are recommended for patients with severe aortic stenosis and heart failure with reduced ejection fraction, as they provide a mortality benefit with a 50% reduction in all-cause mortality (HR 0.5, 95% CI 0.3-0.7) 2, 3
The European Society of Cardiology recommends continuing standard post-myocardial infarction beta-blocker therapy despite severe aortic stenosis 2, 3
Beta-blockers are appropriate for rate control in atrial fibrillation or other arrhythmias requiring rate management in patients with severe aortic stenosis 2, 3
Beta-blockers reduce myocardial oxygen consumption and valve gradients in patients with aortic stenosis and angina 2, 3

Beta-blockers should be avoided in patients with severe aortic stenosis who also have moderate or greater aortic regurgitation (Class IIa recommendation, Level C evidence) 1, 2, 3

The American Heart Association recommends using RAS inhibitors (ACE inhibitors or ARBs) as first-line therapy for hypertension in severe aortic stenosis rather than beta-blockers 1, 2, 3
RAS inhibitors have beneficial effects on left ventricular fibrosis, blood pressure control, dyspnea reduction, and improved effort tolerance in patients with severe aortic stenosis 1, 2, 3

The European Society of Cardiology recommends heart rate control as essential for patients with severe aortic stenosis undergoing non-cardiac surgery, particularly to maintain adequate diastolic filling time 4
Careful fluid management is critical in aortic stenosis during non-cardiac surgery 4
Elective non-cardiac surgery should be postponed until aortic valve replacement is performed if severe aortic stenosis is symptomatic 5

Labetalol can be used with careful monitoring in hypertensive emergencies with severe aortic stenosis, administered as 10-20 mg IV bolus over 2 minutes, followed by continuous infusion at 5-20 mg/h 6
Labetalol should be avoided in patients with 2nd or 3rd degree AV block, systolic heart failure (without reduced EF indication), asthma, or bradycardia 6

The American College of Cardiology recommends assessing for compelling indications such as heart failure with reduced ejection fraction, post-myocardial infarction status, arrhythmias, or angina before using beta-blockers in severe aortic stenosis 1, 2, 3
Concurrent aortic regurgitation should be assessed, and beta-blockers avoided if moderate or greater regurgitation is present 1, 2